IREN Limited (IREN) — RQD Stock Rating Cockpit
IREN Limited (IREN) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh money.
Weak cash conversion or heavy valuation strain compared to actual cash earned.
Insiders and big institutional desks have been trimming shares rather than stepping up to buy.
Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.
2-of-3 JEV AI Jury Bearish Warning on IREN
1.2% ROIC with 68.3% gross margin and -3.08% FCF yield.
Flagged cash-conversion divergence or elevated filing risk disclosures.
Put/Call 1.15x with 21/40 institutional & insider flow.
- ✓Clean SEC annual filing review with no major hidden accounting time-bombs.
- !Priced at 122x earnings—high expectations leave less room for a lukewarm quarter.
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring IREN)
- ✓Live walkthrough of IREN's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
IREN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +167.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on IREN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for IREN. Explore sector supply chains on /butterfly.
IREN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDShould I buy, hold, or sell IREN stock right now?
IREN Limited (IREN) currently earns a Roarable Rating of D+ (Sell — SELL) with 56/100 RQD Confidence. Stretched risk/reward at 122x P/E (1% return on capital) under elevated 10-year interest-rate pressure.
What is IREN's 12-month price target and RQD AI Jury consensus?
IREN's 12-month base price target is $26.01 (range $20.29 to $80.71), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.